Muñoz MC

Idioma: Español
Referencias bibliográficas: 20
Paginas: 207-210
Archivo PDF: 225.61 Kb.

RESUMEN

El cáncer en el embarazo es poco común, entre los tipos mas frecuentes se encuentra el cáncer de mama, linfoma, melanoma y cérvix. El diagnóstico de una malignidad en el embarazo trae una gran preocupación sobre los posibles efectos adversos del tratamiento de la quimioterapia para el feto. Se discutirá y revisara el tema a propósito de un neonato que tuvo exposición a la quimioterapia hasta la semana 20 de embarazo ya que su madre tenía el diagnóstico de linfoma de hodgkin esclerosis nodular.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Avilez A, Niz J. Long term follow up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 1988; 16: 3-6. 11

2. Berry D, Theriault R, Holmes F, et al. Management of breast cancer during pregnancy using a standarized protocol. J Clin Oncol 1999; 17: 855-61.

3. BuekersTE, Thomas L, Chemotherapy in pregnancy. Obstetrics Ginecology 1998, 25 : 323-27

4. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncology. Vol 5, May 2004 , p 289-290

5. Doll D, Ringenberg S, Yarbro J. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-46.

6. Donegan WL. Cancer and prgnacy. CA Cancer Journal Clinics 1983, 33 : 194-214.

7. DurodolaJI. Administration of ciclophosphamide during late pregnancy and early lactation: a case report. Journal National Medicine Association 1979, 71: 165-166

8. Ebert U. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207-20

9. Guillian J, Weinstein L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstretrics and Gynecology Surgery 1983 , 38: 6–13.

10. Lamer E, ChenT, Hoar R. Retinoic acid embriopathy. New England Journal of medicine 1985; 313: 837-41

11. Lampka E, Meder J, Tajer J. the Management of Hodgkin’ s disease during the second trimester of pregnancy. Annals of Oncology 2002, 13 , 2, 423.

12. Li F, Fine W, Jaffe N et al. Offspring of patients treated for cancer in childhood. J Natl Cancer Inst 1979; 62: 1193.

13. Lishner M, Zenickis P, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy.Br J Cancer 1992; 65: 114-7.

14. MorishitaS, Imai A . Acute myelogenous leukemia in pregnancy: fetal blood sampling and early effects of chemotherapy. International Journal of Ginaecology and Obstetrics 1994; 44: 273-77.

15. Pohlman B, Macklis RM. Lymphoma and pregnancy. Seminars Oncology 2000, 27 : 657-66.

16. Reynoso E, Shepherd F, Messner H, et al. Acute leukemia during pregnancy: The Toronto Leukemia Study Group experience with long term follow up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987; 5: 1098-106.

17. San Martin R, Torres S, Leon A. Cancer de mama durante el embarazo y la lactancia. Revista Medica Clinica los Condes 2001, Vol 12 Issue 4 : 33-56

18. Smith LH, Dalrymple JL, Leiserowitz GS, Danielsen B, Gilberth WM. Obstetrical deliveries associated with maternal malignancy in California, 1997, American Journal of Obterics and Ginecology 2001. 184-11 : 1504

19. Tartas N, Foncuberta M. Tratamiento de las neoplasias hematológicas en el embarazo. Revista Medicina Buenos Aires , 2007, 67: 729–736.

20. Toledo T, Harper. Fetal effects during cyclophosfamide and irradiation therapy. Annals Internal Medicine 1987; 74: 87-91.